Tris Pharma, Inc. Sustainability Profile
Tris Pharma, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in developing innovative drug delivery systems, particularly in the areas of paediatrics and chronic pain management. Tris Pharma focuses on creating unique formulations that enhance patient compliance and therapeutic outcomes, setting it apart from competitors. With a strong presence in the US market, Tris Pharma has achieved significant milestones, including the successful launch of several proprietary products that address unmet medical needs. The company’s commitment to research and development, coupled with its expertise in complex formulations, has solidified its position as a trusted partner in the pharmaceutical landscape.
DitchCarbon Score
How does Tris Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tris Pharma, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tris Pharma, Inc.'s reported carbon emissions
Tris Pharma, Inc., headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any specific reduction targets or initiatives related to climate commitments. Without emissions data or defined climate strategies, it is unclear how Tris Pharma is addressing its environmental impact. The absence of reported figures suggests a need for enhanced transparency and commitment to sustainability within the pharmaceutical industry.
How Carbon Intensive is Tris Pharma, Inc.'s Industry?
How Carbon Intensive is Tris Pharma, Inc.'s Location?
Tris Pharma, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tris Pharma, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
